Intas B2B Dossier e-portfolio
- Versions
- Price History
- Description
- FAQ
Version History of Intas B2B Dossier e
5.0.3
April 25, 2024
Minor fixes
5.0.2
April 23, 2024
Minor Improvements
5.0.1
October 20, 2023
Minor improvements and optimizations
5.0
November 4, 2022
Welcome to the new look & feel App Intas b2b bringing you closer through digitlization. New features: - Real time data update - Favourite products - Enhanced filter functions - Country specific Intas b2b news released in different languages
More4.0
January 25, 2021
We have been fixing bugs and making improvements. For the best possible experience and to ensure you have access to all our latest features we suggest you to update this latest version as soon as possible.
More3.2
July 28, 2020
We have been fixing bugs and making improvements. For the best possible experience and to ensure you have access to all our latest features we suggest you to update this latest version as soon as possible.
More3.1.1
June 9, 2020
We have been fixing bugs and making improvements. For the best possible experience and to ensure you have access to all our latest features we suggest you to update this latest version as soon as possible.
More3.1
May 22, 2020
We have been fixing bugs and making improvements. For the best possible experience and to ensure you have access to all our latest features we suggest you to update this latest version as soon as possible.
More3.0
April 9, 2020
Access to Intas Pharmaceutical portfolio Global-Dossiers: Biosimilars, Added Value Products and generics. Access to visual overviews on Dossier related information Always updated with our lasts developments Access to our filing plan and available MA’s Search through our portfolio using filters as stability clime zone, region, therapeutic area… All information also available off-line
More2.7.2
October 30, 2019
Improved performance
Price History of Intas B2B Dossier e
Description of Intas B2B Dossier e
Intas B2B Dossier e: FAQ
Can Intas B2B Dossier e support iPad devices?
Yes, Intas B2B Dossier e is available for iPad users.
Who is the developer of Intas B2B Dossier e?
The Intas B2B Dossier e app was developed by INTAS Pharmaceuticals Limited.
What’s the minimum iOS version supported by the Intas B2B Dossier e app?
Intas B2B Dossier e requires iOS 12.0 or later.
What is the overall user rating for Intas B2B Dossier e?
The Intas B2B Dossier e app doesn’t have enough ratings and reviews yet.
What is the category of the Intas B2B Dossier e app?
Intas B2b Dossier E Relates To The Medical App Genre.
Which version of Intas B2B Dossier e is the latest one?
5.0.3 is the newest version of Intas B2B Dossier e.
What is the date of the latest Intas B2B Dossier e update?
September 18, 2024 is the date of the latest update of the Intas B2B Dossier e app.
When did the Intas B2B Dossier e app come out?
Intas B2B Dossier e officially launched on February 5, 2023.
What age is suitable for the Intas B2B Dossier e app?
Some content may be too intense or graphic for younger viewers, recommended for ages 17 and up.
What languages are available on Intas B2B Dossier e?
The following list of languages is supported by the Intas B2B Dossier e app: English.
Is Intas B2B Dossier e included in the roster of games on Apple Arcade?
No, Intas B2B Dossier e is not on Apple Arcade.
Does Intas B2B Dossier e support in-app purchases?
No, Intas B2B Dossier e does not support in-app purchases.
Does Intas B2B Dossier e provide support for Apple Vision Pro?
No, Intas B2B Dossier e does not provide support for Apple Vision Pro.
Are there commercial ads in Intas B2B Dossier e?
No, there are no commercial ads in Intas B2B Dossier e.
Screenshots of Intas B2B Dossier e
